These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
708 related articles for article (PubMed ID: 16271793)
1. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo. Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793 [TBL] [Abstract][Full Text] [Related]
2. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells. Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980 [TBL] [Abstract][Full Text] [Related]
3. Molecular targeting of BCL2 and BCLXL proteins by synthetic BCL2 homology 3 domain peptide enhances the efficacy of chemotherapy. Dharap SS; Chandna P; Wang Y; Khandare JJ; Qiu B; Stein S; Minko T J Pharmacol Exp Ther; 2006 Mar; 316(3):992-8. PubMed ID: 16291730 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice. Schluep T; Cheng J; Khin KT; Davis ME Cancer Chemother Pharmacol; 2006 May; 57(5):654-62. PubMed ID: 16133526 [TBL] [Abstract][Full Text] [Related]
5. Camptothecin delivery systems: enhanced efficacy and tumor accumulation of camptothecin following its conjugation to polyethylene glycol via a glycine linker. Conover CD; Greenwald RB; Pendri A; Gilbert CW; Shum KL Cancer Chemother Pharmacol; 1998; 42(5):407-14. PubMed ID: 9771956 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of camptothecin and polymer-conjugated camptothecin in tumor spheroids and solid tumors. Ying V; Haverstick K; Page RL; Saltzman WM J Biomater Sci Polym Ed; 2007; 18(10):1283-99. PubMed ID: 17939886 [TBL] [Abstract][Full Text] [Related]
7. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy. Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946 [TBL] [Abstract][Full Text] [Related]
8. Novel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticles. Hong M; Zhu S; Jiang Y; Tang G; Sun C; Fang C; Shi B; Pei Y J Control Release; 2010 Jan; 141(1):22-9. PubMed ID: 19735683 [TBL] [Abstract][Full Text] [Related]
9. Camptothecin delivery systems: the utility of amino acid spacers for the conjugation of camptothecin with polyethylene glycol to create prodrugs. Conover CD; Greenwald RB; Pendri A; Shum KL Anticancer Drug Des; 1999 Dec; 14(6):499-506. PubMed ID: 10834271 [TBL] [Abstract][Full Text] [Related]
10. In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin. Watanabe M; Kawano K; Toma K; Hattori Y; Maitani Y J Control Release; 2008 May; 127(3):231-8. PubMed ID: 18384903 [TBL] [Abstract][Full Text] [Related]
11. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model. Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471 [TBL] [Abstract][Full Text] [Related]
12. Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles. Kawano K; Watanabe M; Yamamoto T; Yokoyama M; Opanasopit P; Okano T; Maitani Y J Control Release; 2006 May; 112(3):329-32. PubMed ID: 16678929 [TBL] [Abstract][Full Text] [Related]
13. PEG-doxorubicin conjugates: influence of polymer structure on drug release, in vitro cytotoxicity, biodistribution, and antitumor activity. Veronese FM; Schiavon O; Pasut G; Mendichi R; Andersson L; Tsirk A; Ford J; Wu G; Kneller S; Davies J; Duncan R Bioconjug Chem; 2005; 16(4):775-84. PubMed ID: 16029018 [TBL] [Abstract][Full Text] [Related]
14. Tumor-targeted delivery of polyethylene glycol-conjugated D-amino acid oxidase for antitumor therapy via enzymatic generation of hydrogen peroxide. Fang J; Sawa T; Akaike T; Maeda H Cancer Res; 2002 Jun; 62(11):3138-43. PubMed ID: 12036926 [TBL] [Abstract][Full Text] [Related]
15. In vitro cytotoxicity and in vivo distribution after direct delivery of PEG-camptothecin conjugates to the rat brain. Fleming AB; Haverstick K; Saltzman WM Bioconjug Chem; 2004; 15(6):1364-75. PubMed ID: 15546204 [TBL] [Abstract][Full Text] [Related]
16. Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101. Svenson S; Wolfgang M; Hwang J; Ryan J; Eliasof S J Control Release; 2011 Jul; 153(1):49-55. PubMed ID: 21406204 [TBL] [Abstract][Full Text] [Related]
17. Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability. Watanabe M; Kawano K; Yokoyama M; Opanasopit P; Okano T; Maitani Y Int J Pharm; 2006 Feb; 308(1-2):183-9. PubMed ID: 16324807 [TBL] [Abstract][Full Text] [Related]
18. Conjugation to increase treatment volume during local therapy: a case study with PEGylated camptothecin. Haverstick K; Fleming A; Mark Saltzman W Bioconjug Chem; 2007; 18(6):2115-21. PubMed ID: 17935287 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vivo antitumor efficacy of PEGylated poly(l-lysine) dendrimer-camptothecin conjugates. Fox ME; Guillaudeu S; Fréchet JM; Jerger K; Macaraeg N; Szoka FC Mol Pharm; 2009; 6(5):1562-72. PubMed ID: 19588994 [TBL] [Abstract][Full Text] [Related]
20. [Effect of total alkaloid of Sophora alopecuroides on SW480 cells and Balb/c nude mice tumor xenograft]. Jiao HL; Yao R; Deng HZ; Wang XJ; Yuan HX; Yao H Zhong Yao Cai; 2011 Jul; 34(7):1090-3. PubMed ID: 22066406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]